
Form D · Kaigene
Celltrion and Taisho partner Kaigene sold $55M in stock, SEC filing shows
A Form D filed Oct. 14 shows the Rockville, Md., autoimmune antibody developer sold nearly $55 million of a planned $73.4 million equity offering to 22 investors. Its newsroom shows no announcement of the raise.
